SSQ-P and SSQ- C
Principal Investigator(s): View help for Principal Investigator(s) Stéphane Gargula, Hopital Necker Enfants Malade
Version: View help for Version V1
Name | File Type | Size | Last Modified |
---|---|---|---|
|
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet | 542.9 KB | 03/28/2022 02:06:AM |
Project Citation:
Gargula, Stéphane. SSQ-P and SSQ- C. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2022-03-28. https://doi.org/10.3886/E150281V1
Project Description
Summary:
View help for Summary
Objectives: Hearing loss is a
frequent disease, which can seriously impact children’s quality of life.
Disease-specific questionnaires, adjusted to each age group, are required to
optimize medical intervention. This study aims to translate, adapt and validate
the French versions of the SSQ-parent (5-18), and SSQ-Children (11-18).
Methods: This is a
controlled, prospective trial, conducted between April and October 2020.
Translation was conducted through the forward-backward technique, and statistical
validation was conducted with a test and re-test 15 days later, on a cases
population and a control population. Cases were included if they were between 5
and 18 years old, and had at least 30 dB hearing loss, unilaterally or
bilaterally.
Results: Mean age was 10.4
years of age for the 54 cases and 12.5 for the 32 controls of the SSQ-parent,
and 13.1 years of age for the 35 cases of the SSQ-children, versus 14.3 for the
35 controls. Respectively, Spearman’s correlation coefficient between global
scores of the test and the re-test was 0.91 (p<0.001), and 0.89
(p<0.001). Both tests were discriminant (respectively, global score 57.8 vs
92 p<0.001, 61.2 vs 92.6 p<0.001), and internally consistent (Cronbach’s
alpha 0.94 and 0.97). Item per item construct validity was very satisfactory.
ROC curves showed very high area under curve for the SSQ-children (0.990), and
SSQ-parent (0.988).
Conclusion: The SSQ-parent and
SSQ-children revealed excellent statistical properties, and can be used for
evaluation of disease-specific quality of life for children with hearing loss.
Related Publications
Published Versions
Report a Problem
Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.
This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.